Abstract
In medicine, objects that need to be removed later - such as stents - are commonly placed in patients, with the time of removal dependent on progress of the patient. In these cases biodegradable materials that last for a specific time may not be suitable. We propose a new class of nanostructured materials that can hold their form as long as wanted, Triggered, Nanostructured Biodegradables (TNBs), that can be disintegrated to micro- or nanoscaled components when externally triggered on command to do so. DNA nanotensegrity microstructures, metastable foams, nanobots and other bioinspired disintegratable scaffold structures are given as potential examples.
Keywords: braces, Prince Rupert's drops, modular nanobot dental, nanobots, tensegrity, stents, surgical implants, Triggered nanostructured biodegradables, tektites
Micro and Nanosystems
Title: Triggered, Nanostructured Biodegradables (TNBs) for Surgical Implants
Volume: 3 Issue: 4
Author(s): Richard Gordon, Stephen M. Levin and Ille C. Gebeshuber
Affiliation:
Keywords: braces, Prince Rupert's drops, modular nanobot dental, nanobots, tensegrity, stents, surgical implants, Triggered nanostructured biodegradables, tektites
Abstract: In medicine, objects that need to be removed later - such as stents - are commonly placed in patients, with the time of removal dependent on progress of the patient. In these cases biodegradable materials that last for a specific time may not be suitable. We propose a new class of nanostructured materials that can hold their form as long as wanted, Triggered, Nanostructured Biodegradables (TNBs), that can be disintegrated to micro- or nanoscaled components when externally triggered on command to do so. DNA nanotensegrity microstructures, metastable foams, nanobots and other bioinspired disintegratable scaffold structures are given as potential examples.
Export Options
About this article
Cite this article as:
Gordon Richard, M. Levin Stephen and C. Gebeshuber Ille, Triggered, Nanostructured Biodegradables (TNBs) for Surgical Implants, Micro and Nanosystems 2011; 3 (4) . https://dx.doi.org/10.2174/1876402911103040284
DOI https://dx.doi.org/10.2174/1876402911103040284 |
Print ISSN 1876-4029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-4037 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transcriptional Regulation of mPGES1 in Cancer: An Alternative Approach to Drug Discovery?
Current Drug Targets Dietary Intervention for Allergic Disease
Current Pharmaceutical Design Non-Ribosomal Halogenated Protease Inhibitors from Cyanobacterial Isolates as Attractive Drug Targets
Current Medicinal Chemistry Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis
Current Vascular Pharmacology Statin Therapy-Evidence Beyond Lipid Lowering Contributing to Plaque Stability
Current Medicinal Chemistry Medical Treatment of Hirsutism in Women
Current Medicinal Chemistry Effects of Altered Plasminogen Activator Inhibitor-1 Expression on Cardiovascular Disease
Current Drug Targets Dietary Intake in HIV-Infected Men with Lipodystrophy: Relationships with Body Composition, Visceral Fat, Lipid, Glucose and Adipokine Metabolism
Current HIV Research Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Current Nanoscience The Role of Vasopressin in Affective Disorders: Possible Targets of Intervention
Central Nervous System Agents in Medicinal Chemistry Basic and Clinical Aspects of Gene Therapy for Retinopathy Induced by Diabetes
Current Gene Therapy Device-based Therapies for Resistant Hypertension
Current Pharmaceutical Design Benefits of Chinese Medicine Among Patients with Diabetic Foot: An Expert Review from Clinical Studies
Current Vascular Pharmacology Drug Delivery Systems with Modified Release for Systemic and Biophase Bioavailability
Current Clinical Pharmacology MicroRNAs as Biomarkers for Birth Defects
MicroRNA A Review on Anti-urease Potential of Coumarins
Current Drug Targets Non-Lipid Effects of Statins: Emerging New Indications
Current Vascular Pharmacology The Forkhead Transcription Factor FOXO3a Controls Microglial Inflammatory Activation and Eventual Apoptotic Injury through Caspase 3
Current Neurovascular Research Metabolomics for Personalized Nutrition Research and Clinical Applications
Current Pharmacogenomics and Personalized Medicine Imidazoline Receptors, Novel Agents and Therapeutic Potential
Cardiovascular & Hematological Agents in Medicinal Chemistry